Jefferies Group’s Wave Life Sciences WVE Stock Holding History

Jefferies Group’s Portfolio WVE Stock Details WVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-23,097	Closed	-$502K	–	2855
2017 Q3	$502K	Buy	+23,097	New	+$464K	﹤0.01%	1632

Other funds holding WVE

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Jefferies Group's WVE Position: Q4 2017 in Review

Jefferies Group sold out of Wave Life Sciences (WVE) in Q4 2017, closing a stake of 23,097 shares — an estimated $502K sold.

Jefferies Group first reported a position in WVE in Q3 2017 and held it in 1 quarter. The position peaked at $502K in Q3 2017. 73 funds tracked by Wall St. Rank hold WVE as of Q4 2017.

Jefferies Group reported no remaining Wave Life Sciences position as of Q4 2017 after selling out during the quarter.
Jefferies Group sold 23,097 Wave Life Sciences shares in Q4 2017, an estimated $502K.
Jefferies Group first reported a position in Wave Life Sciences in Q3 2017 and held it in 1 quarter.
Jefferies Group's Wave Life Sciences position peaked at $502K in Q3 2017.
73 funds tracked by Wall St. Rank held Wave Life Sciences as of Q4 2017.

Based on Jefferies Group's 13F filing for Q4 2017, filed 14 Feb 2018.